Tardive dyskinesia treatment market to reach $3.9 billion by 2030 at 8.3% CAGR, driven by increasing prevalence of psychiatric disorders worldwide.
Read More
Tardive dyskinesia therapeutics market to reach $4.39 billion by 2030 at 7.0% CAGR, driven by increasing prevalence of mental health disorders.
Read More
Tacrolimus market to reach $9.06 billion by 2030 at 5.2% CAGR, driven by rising number of organ transplant procedures and growing geriatric population.
Read More
T cell surface glycoprotein cd3 epsilon chain market to reach $1.89 billion by 2030 at 8.8% CAGR, driven by increasing prevalence of autoimmune diseases.
Read More
T cell specific surface glycoprotein cd28 market to reach $2.58 billion by 2030 at 9.7% CAGR, driven by growing emphasis on personalized medicine approaches.
Read More
T cell receptor based antibody market to reach $6.86 billion by 2030 at 17.7% CAGR, driven by increasing prevalence of cancer and demand for targeted immunotherapies.
Read More
Systemic lupus erythematosus treatment market to reach $5.66 billion by 2030 at 11.3% CAGR, driven by rising number of autoimmune disorders globally.
Read More
Synthetic small molecule active pharmaceutical ingredients market to reach $224.05 billion by 2030 at 6.2% CAGR, driven by rising demand for cost-effective generic drugs.
Read More
Synthetic hormones market to reach $8.34 billion by 2030 at 4.5% CAGR, driven by rising incidence of hormonal imbalances requiring therapeutic intervention.
Read More
Synthetic cannabinoids market to reach $4.91 billion by 2030 at 17.4% CAGR, driven by rising demand for neurological disorder treatments due to aging populations.
Read More